Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 1
1975 1
1977 2
1978 1
1979 1
1980 1
1981 1
1982 2
1983 6
1984 1
1985 1
1986 5
1987 6
1988 8
1989 11
1990 11
1991 21
1992 20
1993 21
1994 20
1995 31
1996 41
1997 38
1998 60
1999 77
2000 107
2001 104
2002 108
2003 129
2004 163
2005 188
2006 226
2007 284
2008 325
2009 366
2010 428
2011 495
2012 561
2013 586
2014 636
2015 701
2016 636
2017 716
2018 694
2019 704
2020 769
2021 169
Text availability
Article attribute
Article type
Publication date

Search Results

8,465 results
Results by year
Filters applied: . Clear all
Page 1
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulović S, Demey W, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte R, Wang J, Huang B, Davis C, Fowst C, Costa N, Blake-Haskins JA, di Pietro A, Grivas P. Powles T, et al. Among authors: park sh. N Engl J Med. 2020 Sep 24;383(13):1218-1230. doi: 10.1056/NEJMoa2002788. Epub 2020 Sep 18. N Engl J Med. 2020. PMID: 32945632 Clinical Trial.
Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis.
Jeon S, Kim TK, Jeong SJ, Jung IH, Kim N, Lee MN, Sonn SK, Seo S, Jin J, Kweon HY, Kim S, Shim D, Park YM, Lee SH, Kim KW, Cybulsky MI, Shim H, Roh TY, Park WY, Lee HO, Choi JH, Park SH, Oh GT. Jeon S, et al. Among authors: park sh. Circulation. 2020 Nov 3;142(18):1736-1751. doi: 10.1161/CIRCULATIONAHA.120.046907. Epub 2020 Sep 4. Circulation. 2020. PMID: 32883094
TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis.
Jeon J, Noh HJ, Lee H, Park HH, Ha YJ, Park SH, Lee H, Kim SJ, Kang HC, Eyun SI, Yang S, Kim YS. Jeon J, et al. Among authors: park sh. Ann Rheum Dis. 2020 Dec;79(12):1635-1643. doi: 10.1136/annrheumdis-2020-217904. Epub 2020 Sep 7. Ann Rheum Dis. 2020. PMID: 32895234 Free PMC article.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Kang YK, Chin K, Chung HC, Kadowaki S, Oh SC, Nakayama N, Lee KW, Hara H, Chung IJ, Tsuda M, Park SH, Hosaka H, Hironaka S, Miyata Y, Ryu MH, Baba H, Hyodo I, Bang YJ, Boku N. Kang YK, et al. Among authors: park sh. Lancet Oncol. 2020 Aug;21(8):1045-1056. doi: 10.1016/S1470-2045(20)30315-6. Epub 2020 Jul 16. Lancet Oncol. 2020. PMID: 32682457 Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Among authors: park sh. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling.
Son J, Cho JW, Park HJ, Moon J, Park S, Lee H, Lee J, Kim G, Park SM, Lira SA, Mckenzie AN, Kim HY, Choi CY, Lim YT, Park SY, Kim HR, Park SH, Shin EC, Lee I, Ha SJ. Son J, et al. Among authors: park sh. Cancer Immunol Res. 2020 Nov;8(11):1393-1406. doi: 10.1158/2326-6066.CIR-19-0828. Epub 2020 Sep 2. Cancer Immunol Res. 2020. PMID: 32878747
8,465 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page